Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15057285 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Experimental: Cabazitaxel 15mg/m2;   Drug: Experimental: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2

Indicates status has not been verified in more than two years